The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Trump Secures Drug Pricing Deals With Nine Pharma Companies 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
France Targets Shein, Temu With Fast-Fashion Fees 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Shein Shares Slide 9% in Hong Kong IPO Debut 
Add as a preferred source on Google
BANGKOK, Thailand, March 22, 2018 -- Amlan International, a leader in the supply of innovative solutions to improve intestinal health and productivity for livestock, announces that Dr. Hyun Soon Lillehoj, a senior research immunologist at the United States Department of Agriculture (USDA), will present on alternatives to in-feed antibiotics at the Asia Pacific Poultry Conference (APPC) in Bangkok, being held March 25–27, 2018.
Dr. Lillehoj is recognized worldwide as a leading authority on the research and development of antibiotic alternatives for the prevention and treatment of poultry diseases. She is the recipient of numerous awards for excellence in research in poultry diseases and health that span her entire career. She will make her presentation, titled “Immune Modulation of Host Response to Coccidiosis and Necrotic Enteritis to Reduce Antibiotics,” on Tuesday, March 27, 2018, in the Crystal A Room, The Athenee Hotel, Bangkok.
“Restrictions on the use of antibiotic growth promoters remain one of the biggest challenges for poultry producers,” says Ron Cravens, president, Amlan International, a Nevada corporation. “We’re delighted to bring Dr. Lillehoj’s expertise to the APPC and, along with our depth of experience in innovative intestinal health additives, provide a productive dialogue on viable approaches to protecting animals from biotoxic challenges to enhance livestock health and performance.”
For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com. Note to media: For an interview with Dr. Lillehoj, please contact Reagan Culbertson at 312.706.3256 (United States), or [email protected].
About Amlan International
Oil-Dri Corporation of America (NYSE:ODC), a Delaware corporation doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois. In 2017, the company added the Richard M. Jaffee Laboratory for Applied Microbiology to the campus.
Amlan International sells animal health products outside of the United States, and product availability may vary by country. Product-associated claims do not constitute medical claims and may differ based on government requirements. The information contained herein is based on Amlan’s research and you should conduct your own tests to determine the suitability of Amlan’s products for your specific purposes. “Amlan,” “Varium” and “NeoPrime” are trademarks of Oil-Dri Corporation of America.
Reagan B. Culbertson
Media Contact
[email protected]
